BIOMAT Database Logo BIOMAT Database Logo

Treatment of malignant gliomas in adults using a combination of adriamycine, VM 26 and CCNU: results of a type II trial. 1977

P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot

UI MeSH Term Description Entries
D008130 Lomustine An alkylating agent of value against both hematologic malignancies and solid tumors. CCNU,Belustine,Cecenu,CeeNU,NSC-79037,NSC 79037,NSC79037
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D011034 Podophyllotoxin A lignan (LIGNANS) found in PODOPHYLLIN resin from the roots of PODOPHYLLUM plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and may have antineoplastic properties, as do some of its congeners and derivatives. Epipodophyllotoxin,CPH86,Condyline,Condylox,Podocon-25,Podofilm,Podofilox,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a alpha,9 beta))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer,Podophyllotoxin, (5R-(5 alpha,5a beta,8a alpha,9 beta))-Isomer,Wartec,Warticon
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell

Related Publications

P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial.
January 1977, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
[Letter: Chemotherapy of operated malignant brain gliomas using a combination of VM 26 and CCNU].
February 1976, La Nouvelle presse medicale,
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
[Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial].
June 1976, La Nouvelle presse medicale,
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
[Treatment of inoperable glioblastomas using a combination of adriamycin, VM 26 and CCNU].
January 1977, Bulletin du cancer,
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors.
March 1979, Surgical neurology,
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
Combination chemotherapy with VM 26 and CCNU in primary malignant brain tumors of children.
March 1980, Helvetica paediatrica acta,
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas.
April 1992, Journal of chemotherapy (Florence, Italy),
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
Enhancement of bone marrow toxicity of VM-26-CCNU combination by bleomycin.
December 1977, Cancer treatment reports,
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
Phase II trial of VM-26 in patients with metastatic malignant melanoma.
March 1978, Cancer treatment reports,
P Pouillart, and G Mathe, and T H Thy, and J Lheritier, and M Poisson, and P Huguenin, and H Gautier, and P Morin, and R Parrot
VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report.
February 1981, Surgical neurology,
Copied contents to your clipboard!